Two Duke faculty members will be honored Thursday with the state’s highest civilian honor, the North Carolina Award. Governor Roy Cooper will present the award to Timothy B. Tyson for literature and to Blake S. Wilson for science.

Duke researchers are urging the World Health Organization to recognize talaromycosis as a neglected tropical disease, a move that could bring it needed attention.

This year's Outstanding Achievement Awards from the Society of Neuroscience (SfN) will honor a group of leading researchers that includes Nicolas Brunel, Duke University professor of neurobiology and of physics.

An interview with Dr. Paul Modrich, James B. Duke Professor of Biochemistry and Professor of Chemistry at Duke University. Dr. Modrich was awarded the 2015 Nobel Prize for Chemistry jointly with Tomas Lindahl of the Francis Crick Institute and Clare Hall Laboratory in the UK, and Aziz Sancar of University of North Carolina, Chapel Hill, for mechanistic studies of DNA repair.

Kevin Thomas MD, Associate Professor of Medicine, has been named Duke University School of Medicine’s first Vice Dean for Diversity, Equity and Inclusion.

Dr. Charlene Wong works to improve and protect the health of the community

At age 93, Pearl Asbury joined a study at the Duke CTSI office in Kannapolis at the North Carolina Research Campus to better understand kidney disease in people of African ancestry. “I always wanted to be involved in a study just for Afro-Americans. It is wonderful because for so much of our history, our health has not been understood,” said Asbury, who became the 100th person to enroll.

Duke CTSI, Duke University School of Medicine, and Duke University Health System together have launched a new initiative aimed at achieving equitable representation in clinical research.

The Duke University School of Medicine has been selected as one of 11 medical schools from across the United States and Canada to participate in

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.